Horizon Therapeutics plc Makes Founding Gift to Support the University of Notre Dame's Patient Advocacy Initiative

Novel Program Supports Student Education and Future Careers in Patient Advocacy Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University

Related Keywords

Ireland ,Tim Walbert ,Santiago Schnell ,Barbara Calhoun ,Matt Flesch ,Notre Dame ,Rareis Instagram ,Ray Gordon ,Patient Advocacy Initiative ,Instagram ,Linkedin ,Twitter ,Williamk Warren Foundation ,College Of Science ,Nasdaq ,Novel Program Supports Student Education ,University Of Notre Dame Patient Advocacy Initiative ,Notre Dame College Of Science ,Notre Dame Patient Advocacy Initiative ,University Of Notre Dame ,Boler Parseghian Center ,Facebook ,Future Careers ,Patient Advocacy ,Interdisciplinary Minor ,Patient Advocacy Summit ,Rare Disease Weekend ,Horizon Therapeutics ,Notre Dame College ,Neglected Diseases ,Horizon ,Herapeutics ,Akes ,Founding ,Gift ,Support ,University ,Otre ,Name ,Patient ,Advocacy ,Initiative ,